$24.040
-2.024 (-8.42%)Zum Schluss
SPTX im Vergleich zur Peergroup
In the context of the broader market, SPTX competes directly with industry leaders such as MLTX and MNKD. With a market capitalization of $1.29B, it holds a significant position in the sector. When comparing efficiency, SPTX's gross margin of N/A stands against MLTX's N/A and MNKD's 69.00%. Such benchmarking helps identify whether Seaport Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Seaport Therapeutics Inc
The company has a current ratio of 18.00, indicating strong liquidity, and total equity increased significantly to $422.6 million in Q2 2026, showing improved financial health.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.